Clinical Trial: A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07221357) titled 'A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer' on Oct. 23.

Brief Summary: The purpose of this study is to evaluate the safety and efficacy of pumitamig in combination with chemotherapy versus bevacizumab in combination with chemotherapy in participants with previously untreated, unresectable, or metastatic colorectal cancer

Study Start Date: March 04, 2026

Study Type: INTERVENTIONAL

Condition: Untreated, Unresectable, or Metastatic Colorectal Canc...